All In MedTech

Device Trial Radar · NCT07888738

Evaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary Procedures

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

320

Planned (sponsor's estimate)

Start

Dec 1, 2026

Primary completion

Nov 2027

Study completion Nov 2027

Sponsor

Lead sponsor
Terumo Europe N.V.Public (4543.T)
Sponsor type
Industry
First posted
Oct 22, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical study has been organised to learn more about the safety and use of the TR Band Distal device in patients who have had a heart procedure through a blood vessel in the wrist near the base of the thumb (called distal radial access). The study will look at how well the device helps stop bleeding after the procedure, while still allowing blood to flow normally through the blood vessel in the wrist.

Conditions

  • Hemostasis
  • Distal Radial Artery Access (dTRA)

Interventions

  • TR Band DistalDevice

    Coronary procedure via distal radial access using the TR Band Distal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Subjects Achieving Successful Hemostasis Within 24 HoursTime frame: Within 24 hours following the index procedure

Locations

7 sites in 4 countries. Site status is shown where the registry gives one.

  • Krankenhaus Eisenstadt

    Eisenstadt, Austria

  • Cliniques universitaires Saint-Luc

    Brussels, Belgium

  • CHU Charleroi

    Charleroi, Belgium

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.